Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kim, Ji Bak ^a   Park, Kyeongsoon ^b   Ryu, Jiheun ^c   Lee, Jae Joong ^a   Lee, Min Woo ^d   Cho, Han Saem ^c   Nam, Hyeong Soo ^d   Park, Ok Kyu ^b   Song, Joon Woo ^a   Kim, Tae Shik ^c   Oh, Dong Joo ^a   Gweon, DaeGab ^c   Oh, Wang Yuhl ^c   Yoo, Hongki ^d   Kim, Jin Won ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; MACROPHAGE; MALE; METABOLISM; PROCEDURES; RABBITS AND HARES;

ANIMALS; ATHEROSCLEROSIS; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MICE, INBRED C57BL; OPTICAL IMAGING; RABBITS; RECEPTORS, CELL SURFACE;

EID: 84960364259     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22608     Document Type: Article

References (36)

1. Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422 (2011).
2. Narula, J. et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J. Am. Coll. Cardiol. 61, 1041-1051 (2013).
3. Otsuka, F., Joner, M., Prati, F., Virmani, R. & Narula, J. Clinical classification of plaque morphology in coronary disease. Nat. Rev. Cardiol. 11, 379-389 (2014).
4. Stone, G. W. et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364, 226-235 (2011).
5. Galis, Z. S., Sukhova, G. K., Lark, M. W. & Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493 (1994).
6. Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G. & Galis, Z. S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98, 2572 (1996).
7. Sukhova, G. K., Shi, G.-P., Simon, D. I., Chapman, H. A. & Libby, P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102, 576 (1998).
8. Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355 (2011).
9. Chen, J. et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105, 2766-2771 (2002).
10. Kolodgie, F. D. et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108, 3134-3139 (2003).
11. Deguchi, J. O. et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114, 55-62 (2006).
12. Shepherd, J. et al. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem. Biol. 14, 1221-1231 (2007).
13. Waldeck, J. et al. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an α vβ 3 integrin-targeted fluorochrome. J. Nucl. Med. 49, 1845-1851 (2008).
14. Jaffer, F. A., Libby, P. & Weissleder, R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1017-1024 (2009).
15. Yoo, H. et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat. Med. 17, 1680-1684 (2011).
16. Tearney, G. J. et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc. Imaging 1, 752-761 (2008).
17. Lee, S. et al. Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels. Circ. Cardiovasc. Interv. 7, 560-569 (2014).
18. Kim, S. et al. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery. European Heart Journal. DOI: http://dx.doi.org/10.1093/eurheartj/ehv726 (2016).
19. Tahara, N. et al. 2-deoxy-2-[18 F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis. Nat. Med. 20, 215-219 (2014).
20. Finn, A. V. et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 59, 166-177 (2012).
21. Chinetti-Gbaguidi, G., Colin, S. & Staels, B. Macrophage subsets in atherosclerosis. Nat. Rev. Cardiol. 12, 10-17 (2015).
22. Zhang, X. S., Brondyk, W., Lydon, J. T., Thurberg, B. L. & Piepenhagen, P. A. Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases. J. Inherit. Metab. Dis. 34, 795-809 (2011).
23. Linehan, S. A., Martinez-Pomares, L., Stahl, P. D. & Gordon, S. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: In situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J. Exp. Med. 189, 1961-1972 (1999).
24. Weissleder, R., Nahrendorf, M. & Pittet, M. J. Imaging macrophages with nanoparticles. Nat Mater 13, 125-138 (2014).
25. Weissleder, R. & Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med. 9, 123-128 (2003).
26. Mulder, W. J., Jaffer, F. A., Fayad, Z. A. & Nahrendorf, M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci. Transl. Med. 6, 239sr231-239sr231 (2014).
27. Lobatto, M. E. et al. Atherosclerotic Plaque Targeting Mechanism of Long-Circulating Nanoparticles Established by Multimodal Imaging. ACS nano 9, 1837-1847 (2015).
28. Kean, T. & Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62, 3-11 (2010).
29. Zhang, Y. & Zhang, M. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J. Biomed. Mater. Res. 62, 378-386 (2002).
30. Bodnar, M., Hartmann, J. F. & Borbely, J. Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles. Biomacromolecules 7, 3030-3036 (2006).
31. Kim, J. H. et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control. Release 111, 228-234 (2006).
32. Son, Y. J. et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J. Control. Release 91, 135-145 (2003).
33. Cole, A. J. et al. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32, 2183-2193 (2011).
34. Jaffer, F. A. et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115, 2292-2298 (2007).
35. Jaffer, F. A. et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 118, 1802-1809 (2008).
36. Lichtman, J. W. & Conchello, J.-A. Fluorescence microscopy. Nat Meth 2, 910-919 (2005).